| 发明名称 |
METHOD FOR TREATMENT OF A PATIENT SUFFERING FROM I OR II STAGE OF SYSTEMIC LUPUS ERYTHEMATOSUS |
| 摘要 |
In various embodiments, the present invention relates to a method for the treatment of a patient suffering from I or II stage of systemic lupus erythematosus (SLE), comprising weekly administering in a dosage from about 1 to about 10 mg/kg during about 2 to about 52 weeks of a fusion molecule which comprises TACI extracellular domain or fragment thereof which binds BiyS, and a human immunoglobulin-constant domain. |
| 申请公布号 |
EA022911(B1) |
申请公布日期 |
2016.03.31 |
| 申请号 |
EA20090001630 |
申请日期 |
2008.06.13 |
| 申请人 |
ZYMOGENETICS, INC.;ARES TRADING S.A. |
发明人 |
BUSBY Sharon, J.;GROSS Jane, A.;VISICH Jennifer;NESTOROV Ivan;MUNAFO Alain;PAPASOULIOTIS Orestis;PENA ROSSI Claudia |
| 分类号 |
A61K9/06;A61K9/00;A61K38/00 |
主分类号 |
A61K9/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
